Professional inspection systems are smarter,  more robust, and offer numerous benefits for your manufacturing environment.


Unlike conventional smart cameras, OPTEL’s PC-based vision systems offer much higher processing power, providing you with the capability and versatility to process complex tasks.


Our solutions are also traceability-ready. Imagine the visibility you would gain by tracking your devices all the way to the patient and accessing all the valuable data generated at every step of the supply chain.


Plus, we take care of integration, so no need to prepare IQ/OQ documentation. Our experts make sure your system is installed correctly and works throughout its lifetime.

Smart cameras can’t do all that.
We can.

Be smarter. Contact us.

info@optelgroup.com | optelgroup.com/medical-devices

info@optelgroup.com

optelgroup.com/medical-devices

CONTACT IMAGE SENSOR
TECHNOLOGY

  • 100% label inspection
    (artwork and variable data)
    in a compact design
  • Superior performance:
    Up to 24,000 inspections/minute
  • Switch printing materials without
    changing system configurations
    on large web printers
  • Now available for desktop labelers

DOWNLOAD THE DATASHEET

OPTEL’S SEAL INSPECTION
SOLUTION

  • Detects foreign-body contaminants, creases, poor sealing contact
  • Ensures consistency of inspections,
    minimizing impact on OEE
  • Easy access to preloaded batch
    and lot numbers to avoid human error
  • Fast, 100% automatic seal inspections
  • Compact design conforms to ISO 7 standards for cleanrooms

DOWNLOAD OUR USE CASE:

ENSURING THE QUALITY OF MEDICAL DEVICES

Go to article: Home | Pause for thoughtGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Datwyler Company Insight Go to article: DatwylerGo to article: NewsGo to article: BaxterGo to article: Covid-19 executive briefing by GlobalDataGo to article: ELPRO Monitoring SolutionsGo to article: Abivax’s ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for successGo to article: Abiomed’s Impella receives FDA Emergency Use Authorization during Covid-19Go to article: FargoGo to article: Disruptions to global oncology trials have fallen to a three-month lowGo to article: MimotopesGo to article: AstraZeneca/Oxford University and CanSino publish promising Covid-19 vaccine cliGo to article: Biotech IPO valuation relies on data to enter capital markets during Covid-19 paGo to article: Nelson LabsGo to article: The pharma industry briefingGo to article: Pfeiffer VacuumGo to article: A century of cultures: celebrating the world’s oldest lab culture collectionGo to article: SkyepharmaGo to article: Gut feeling: exploring the therapeutic potential of the gut-brain axisGo to article: OptelGo to article: Crabby concoctions: why pharma’s thirst for crustacean blood is up for debateGo to article: Air FranceGo to article: Debunking myths about puberty blockers for transgender childrenGo to article: MicronovaGo to article: Hiring from home: pharma recruitment in the age of Covid-19 Go to article: Nipro PharmapackagingGo to article: Q&A: breaking new ground in pharma packaging with HoneywellGo to article: WipotecGo to article: Treatment-resistant rare diseases: exploring landmark drug approvals in 2020Go to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Modernising pharma patents: can AI be an inventor?Go to article: ILC Dover Go to article: Boosting agility to accelerate project timescales Go to article: Scandinavian HealthGo to article: Doing the right thing: the enhanced case for complianceGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue